AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Processa Pharmaceuticals, Inc. Director's Dealing 2023

Oct 23, 2023

35172_dirs_2023-10-23_fe99af1f-9c0c-4f0d-8e9e-eb64b61e020b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2023-10-12

Reporting Person: Yorke Justin W (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-12	Common Stock	A	6000	$0.3	Acquired	74729	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	519890	Indirect

Footnotes

F1: Amendment filed solely to correct the amount directly owned reported on the Form 4 filed October 12, 2023 and the Form 4 filed on October 10/10/2023.